Analystreport

Castle Biosciences, Inc. (NASDAQ: CSTL) was given a new $30.00 price target on by analysts at Guggenheim. They now have a "buy" rating on the stock.

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report